• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  2-(3,7-Dimethyl-octa-2, 6-dienyl)—6-ethylamino-3-hydroxy-5-pentyl-[1,4]benzoquinone
Trade Name:  N/A
Date Designated:  02/01/2018
Orphan Designation:  Treatment of Huntington’s Disease (HD)
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Marketing Approval Date:  N/A
Approved Labeled Indication:  
Exclusivity End Date:    N/A
Emerald Health Pharmaceuticals Inc.
5820 Nancy Ridge Drive
San Diego, California 92121

The sponsor address listed is the last reported by the sponsor to OOPD.